Abstract

We come from the perspective that opioids are efficacious in the management of nonterminal chronic pain. Responsible care within such a model requires that pain management physicians are adequately familiar with the broad ordering and interpretation of urine toxicology specimens, and especially with interpretation specific to issues of opiate use, addiction, and diversion as commonly seen in the course of clinical care, including risk assessment. This article provides an overview of these and related concerns.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.